CGON CG Oncology, Inc.
$61.56▼ -0.24%
Healthcare
Other
Volume 880.2K
Avg Volume (10D) 959.2K
Key Metrics & Fundamentals
Market Cap
$5.46B
P/E Ratio
–
Div Yield
0.00%
52W Range
35.80 - 80.97
% vs 50 MA
-12.76%
% vs 200 MA
-6.31%
RSI-14
37.2
MACD Histogram
+0.2100
Beta (1Y vs SPY)
1.09
Free Cash Flow
-$46.88M
Gross Rev
$1.16M
Gross Profit
-$2.77M
EBITDA
-$85.55M
COGS
$3.93M
Operating Exp
$83.63M
Operating Income
-$86.40M
EBIT
-$86.40M
Pretax Income
-$79.06M
Net Income
-$79.06M
EPS (Diluted)
-0.90
Price & Volume History
Loading chart…
Recent News
How Investors May Respond To CG Oncology (CGON) Hiring a CCO Before Potential Bladder Cancer Launch
Simply Wall St. · Oct 13, 2026 10:10 PM ET
CG Oncology Appoints Proven Biopharmaceutical Commercial Leader Isabel Kalofonos as Chief Commercial Officer
GlobeNewswire · Oct 13, 2026 8:00 AM ET
3 Stocks Call Traders Are Targeting Today
Schaeffer's Investment Research · Sep 11, 2026 11:35 AM ET
CG Oncology (CGON) Stock Looks Fully Priced After A 160% Run
Simply Wall St. · Sep 3, 2026 9:06 AM ET
Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
PR Newswire · Aug 26, 2026 10:41 AM ET
BofA Adjusts Price Target on CG Oncology to $88 From $87
MT Newswires · Aug 7, 2026 8:10 AM ET
RBC Adjusts PT on CG Oncology to $79 From $81, Maintains Outperform Speculative Risk Rating
MT Newswires · Aug 7, 2026 7:15 AM ET
CG Oncology, Inc. (CGON) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 6, 2026 9:50 AM ET
CG Oncology Q2 Net Loss Widens
MT Newswires · Aug 6, 2026 8:39 AM ET
CG Oncology Reports Second Quarter 2026 Financial Results and Provides Business Updates
GlobeNewswire · Aug 6, 2026 8:15 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CGON's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.